Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma

NCT04525209 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics

Interventions

OTHER: No intervention

Sponsor

Ruijin Hospital